Skip to main content

Central Airway Obstruction

2
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Airiver Medical
Airiver MedicalMN - Brooklyn Park
1 program
1
Paclitaxel-Coated Pulmonary Balloon CatheterPhase 1
Libra Therapeutics
Libra TherapeuticsCA - San Diego
1 program
1
Paclitaxel-Coated Pulmonary Balloon CatheterPhase 11 trial
Active Trials
NCT05895305Active Not Recruiting45Est. Oct 2029

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
2027
2028
2029
Libra TherapeuticsPaclitaxel-Coated Pulmonary Balloon Catheter

Clinical Trials (1)

Total enrollment: 45 patients across 1 trials

NCT05895305Libra TherapeuticsPaclitaxel-Coated Pulmonary Balloon Catheter

Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Airway Stenosis

Start: May 2023Est. completion: Oct 202945 patients
Phase 1Active Not Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.